← All trials
NCT03264157
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 8, 2017
- Primary completion
- Jul 13, 2018
- Completion date
- Feb 28, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 162
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Bio Products LaboratoryLead sponsor
- Bio Products LaboratoryStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.